PharmaJet partner touts interim safety results for needle-free COVID-19 vaccine

[Image from PharmaJet]

PharmaJet announced today that its partner, Technovalia, reported positive interim safety results from a needle-free COVID-19 vaccine trial.

Golden, Colorado-based PharmaJet’s needle-free injection systems are being studied with Covigen, a DNA-based vaccine developed by French-Thai pharmaceutical company BioNet-Asia in collaboration with Melbourne, Australia-based Technovalia. Enrollment for the trial began in June 2021.

Get the full story at our sister site, Drug Delivery Business News.

Read more
  • 0

PharmaJet partner touts interim safety results for needle-free COVID-19 vaccine trial

[Image from PharmaJet]PharmaJet announced today that its partner, Technovalia, reported positive interim safety results from a needle-free COVID-19 vaccine trial.

Golden, Colorado-based PharmaJet’s needle-free injection systems are being studied with Covigen, a DNA-based vaccine developed by French-Thai pharmaceutical company BioNet-Asia in collaboration with Melbourne, Australia-based Technovalia. Enrollment for the trial began in June 2021.

Get the full story at our sister site, Drug Delivery Business News.

Read more
  • 0

PharmaJet partner announces COVID-19 vaccine trial with needle-free injection tech

[Image from PharmaJet]PharmaJet announced today that one of its pharmaceutical partners, Nykode Therapeutics, has begun a trial for a COVID-19 vaccine with PharmaJet’s needle-free injection technology.

Nykode’s Phase 1/2 clinical trial will specifically address the emerging SARS-CoV-2 variants, with the DNA-based vaccines delivered intramuscularly with PharmaJet’s Stratis needle-free injection system.

Get the full story at our sister site, Drug Delivery Business News.

Read more
  • 0

Scancell picks PharmaJet’s needle-free injection systems to deliver COVID-19 vaccine candidates

PharmaJet announced today that its partner, Scancell, chose its needle-free injection platform to administer its COVID-19 vaccine candidates.

Scancell selected Golden, Colorado-based PharmaJet’s devices to administer two SARS-CoV-2 DNA-based vaccine candidates, SCOV1 and SCOV2. The vaccines will be exclusively administered using the PharmaJet Tropis and PharmaJet Stratis needle-free injection systems.

Get the full story at our sister site, Drug Delivery Business News.

Read more
  • 0

PharmaJet begins enrollment for needle-free COVID-19 vaccine trial

PharmaJet announced today that it began enrollment for a Phase 1 clinical trial for its needle-free COVID-19 vaccine in Australia.

Golden, Colo.-based PharmaJet’s needle-free injection systems will be studied with Covigen, a DNA-based vaccine developed by French-Thai pharmaceutical company BioNet-Asia in collaboration with Melbourne, Australia-based Technovalia.

Get the full story at our sister site, Drug Delivery Business News.

Read more
  • 0